FDA agrees to review Moderna mRNA flu vaccine in dramatic reversal
Scientific American [Unofficial]
February 18, 2026
After initially rejecting Moderna’s application for review, the FDA will now consider the company’s mRNA flu shot
Discussion in the ATmosphere